{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-174803","form_type":"8-K","ticker":"NERV","cik":"0001598646","company_name":"Minerva Neurosciences, Inc.","filed_at":"2022-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.382979+00:00","generated_at":"2026-06-25T01:36:16.684610+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Minerva Neurosciences shareholders approve reverse stock split ratio of 1:4 to 1:10","bullets":["Reverse stock split authorized by 93.5% of votes cast (25.9M for, 1.7M against).","Three directors elected: Hilleman, Laghrissi-Thode, Luthringer (each with ~16M for).","Advisory say-on-pay approved with 17.4M for, 891K against, 9.3M broker non-votes.","Deloitte & Touche ratified as auditor for FY2022 with 27.1M for, 552K against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-174803","json":"https://secwatch.observer/filing/0001193125-22-174803.json","markdown":"https://secwatch.observer/filing/0001193125-22-174803.md","text":"https://secwatch.observer/filing/0001193125-22-174803.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522174803/0001193125-22-174803-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522174803/d315229d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:36:16.684610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}